Delivery Order SPE2DB22D3010-SPE2DB26FP0RH
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zenzedi Tabs 20mg, a brand-name amphetamine-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $6,392.73, was competitively awarded without a set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zenzedi Tabs 30mg with a ceiling value of $1,883.91. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award was made competitively with no set-aside designation, leveraging the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,272.74 to AmerisourceBergen Drug Corp for Zenzedi 15 mg tablets (30-count supply) with a firm fixed price and ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The...
- The Defense Logistics Agency Troop Support Medical awarded a $185,070 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561500641 Zenzedi tablets. Under this order, Amerisourcebergen will deliver 30mg Zenzedi tablets to a location in Conshohocken, Pennsylvania by July 17, 2023 to support the Defense Logistics Agency's medical supply needs. As a top tier medical product supplier, Amerisourcebergen will fulfill this delivery order from its corporate headquarters...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.44, is a delivery order for the supply of Zenzedi 20 mg tablets. It is a firm fixed-price contract with a performance period ending on May 12, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and there is...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $262 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 15 mg Zenzedi tablets. The firm fixed price order calls for the delivery of 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required from August 23 to August 24, 2023. The Defense Logistics Agency Troop Support Medical establishes contracts to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,527.76 contract is for the delivery of ZENZEDI TABS 20MG, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,521.90 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order, issued under a firm fixed price contract type, covers the supply of ADZENYS XR ODT Tablets 1's 6.3MG, a prescription medication used in the treatment of attention-deficit/hyperactivity disorder....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,667.60, is a delivery order for the supply of ZENZEDI 20 MG TABLET 30S, a medication product. The contract has a firm fixed price pricing type and a completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0RHDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Zenzedi 20 mg tablets valued at $1,636.38 with a firm fixed price contract type. The award was issued on October 15, 2025, with an ultimate completion date of October 16, 2025, and the place of performance is located in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical supply capabilities. The company's DLA prime contract vehicle enables it to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. This particular delivery order for Zenzedi, an amphetamine-based medication used for attention deficit hyperactivity disorder treatment, reflects the company's ongoing role in fulfilling federal healthcare supply requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/15/25 |